Merck & Co Inc [NYSE: MRK] gained 2.94% on the last trading session, reaching $97.76 price per share at the time.
Merck & Co Inc represents 2.49 billion in outstanding shares, while the company has a total market value of $242.64 billion with the latest information. MRK stock price has been found in the range of $95.36 to $100.27.
If compared to the average trading volume of 12.60M shares, MRK reached a trading volume of 23150033 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Merck & Co Inc [MRK]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for MRK shares is $103.18 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on MRK stock is a recommendation set at 1.97. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Scotiabank have made an estimate for Merck & Co Inc shares, keeping their opinion on the stock as Sector Outperform, with their previous recommendation back on November 13, 2025. While these analysts kept the previous recommendation, Citigroup raised their target price to Neutral. The new note on the price target was released on October 13, 2025, representing the official price target for Merck & Co Inc stock. Previously, the target price had yet another raise to $90, while Berenberg analysts kept a Hold rating on MRK stock.
The Price to Book ratio for the last quarter was 4.69, with the Price to Cash per share for the same quarter was set at 7.35. Price to Free Cash Flow for MRK in the course of the last twelve months was 18.59 with Quick ratio for the last quarter at 1.44.
Trading performance analysis for MRK stock
Merck & Co Inc [MRK] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 5.21. With this latest performance, MRK shares gained by 12.14% in over the last four-week period, additionally plugging by 26.01% over the last 6 months – not to mention a drop of -1.73% in the past year of trading.
Merck & Co Inc [MRK]: A deeper dive into fundamental analysis
Operating Margin for any stock indicates how profitable investing would be, and Merck & Co Inc [MRK] shares currently have an operating margin of 39.79% and a Gross Margin at 75.81%. Merck & Co Inc’s Net Margin is presently recorded at 29.79%.
Merck & Co Inc (MRK) Capital Structure & Debt Analysis
According to recent financial data for Merck & Co Inc. ( MRK), the Return on Equity (ROE) stands at 39.51%, highlighting impressive shareholder gains. The Return on Assets (ROA) is 15.41%, reflecting the company’s efficiency in generating profits from its assets. Additionally, Merck & Co Inc’s Return on Invested Capital (ROIC) is 20.73%, showcasing its effectiveness in deploying capital for earnings.
Merck & Co Inc (MRK) Efficiency & Liquidity Metrics
Based on Merck & Co Inc’s (MRK) latest financial statements, the Debt-to-Equity Ratio is 0.80%, indicating its reliance on debt financing relative to shareholder equity.
Merck & Co Inc (MRK) Efficiency & Liquidity Metrics
From an operational efficiency perspective, Merck & Co Inc. (MRK) effectively leverages its workforce, generating an average of $253733.33 per employee. The company’s liquidity position is robust, with a Current Ratio of 1.66% and a Quick Ratio of 1.44%, indicating strong ability to cover short-term liabilities.
Merck & Co Inc [MRK]: An earnings per share (EPS) analysis
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for MRK. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Merck & Co Inc go to 10.16%.
An analysis of Institutional ownership at Merck & Co Inc [MRK]
There are presently around $80.28%, or 80.33%% of MRK stock, in the hands of institutional investors. The top three institutional holders of MRK stocks are: VANGUARD GROUP INC with ownership of 244.68 million shares, which is approximately 9.6558%. BLACKROCK INC., holding 207.3 million shares of the stock with an approximate value of $$25.66 billion in MRK stocks shares; and BLACKROCK INC., currently with $$14.63 billion in MRK stock with ownership which is approximately 4.6365%.
